랫드에서 Perfluorooctanoic Acid의 독성에 관한 연구 = Toxicological effects of perfluorooctanoic acid in rats

다국어 초록 (Multilingual Abstract)

Perfluorooctanoic acid (PFOA), a member of the perfluoroalkyl acids that have wide commercial applications, is persistent organic pollutants widely spread throughout the environment and human population. But little is known about the adverse biological effects of the PFOA. In the present study, the toxicological effects of PFOA were investigated in rats. Sprague-Dawley rats (N = 10 in each group) were orally administered with PFOA in drinking water for 4 weeks (0, 100, 200, or 400 ppm in male, and 0, 200, 400, or 800 ppm in female). Three female rats given 800 ppm died during the study. PFOA treatment decreased the body weight gain and increased the liver weights in both genders. Serum biochemical investigations revealed significant increases in the aspartate aminotransferase, alanine transaminase, alkaline phosphatase, blood urea nitrogen, total cholesterol, and total bilirubin in male but in female. Serum estradiol (E2) levels were increased in all treated rats. Histopathologically, hepatocellular hypertrophy around central vein was noted in the liver of treated rats. No significant histopathological changes were noted in other organs. In conclusion, PFOA induced toxicological changes in the liver and increased serum E2 level which was not related to histopathological changes of endocrine and reproductive system.

참고문헌 (Reference)

1 유승석, "불소수지 코팅 주방기구의 안전성 평 가" 식품의약품안전청연구보고서 2276-2277, 2004

2 Vanden Heuvel JP, "Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats" 6 : 83-92, 1991

3 Kennedy GL Jr, "The toxicology of perfluorooctanoate" 34 : 351-384, 2004

4 Liu RC, "The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro" 30 : 102-108, 1996

5 Butenhoff JL, "The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum" 114 : 1776-1782, 2006

6 Olson CT, "The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids" 70 : 362-372, 1983

7 Peden-Adams MM, "Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid" 70 : 1130-1141, 2007

8 Takagi A, "Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8- hydroxydeoxyguanosine in liver DNA of rats" 57 : 55-60, 1991

9 Kudo N, "Sex hormone-regulated renal transport of perfluorooctanoic acid" 139 : 301-316, 2002

10 Calafat AM, "Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the national health and nutrition examination survey (NHANES)" 41 : 2237-2242, 2007

11 Panaretakis T, "Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid" 173 : 56-64, 2001

12 Abbott BD, "Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha" 98 : 574-581, 2007

13 Asakawa A, "Perfluorooctane sulfonate influences feeding behavior and gut motility via the hypothalamus" 19 : 733-739, 2007

14 Kannan K, "Perfluorooctane sulfonate and related fluorochemicals in human blood from several countries" 38 : 4489-4495, 2004

15 Begley TH, "Perfluorochemicals: potential sources of and migration from food packaging" 22 : 1023-1031, 2005

16 Fei C, "Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort" 115 : 1677-1682, 2007

17 Ashby J, "Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis" 13 : 1-117, 1994

18 Biegel LB, "Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats" 60 : 44-55, 2001

19 Perkins RG, "Investigation of ammonium perfluorooctanoate effect on hormone levels and peroxisomal proliferation in the rat" 12 : 38-, 1992

20 Liu SC, "Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: Estrogen induction of TGF alpha production" 1 : 683-692, 1987

21 Karrman A, "Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden" 115 : 226-230, 2007

22 Ishibashi H, "Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro" 30 : 1358-1359, 2007

23 Maras M, "Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation" 114 : 100-105, 2006

24 Biegel LB, "Effects of ammonium perfluorooctanoate on Leydig cell function: In vitro, in vivo, and ex vivo studies" 134 : 18-25, 1995

25 Liu RC, "Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats" 30 : 220-228, 1996

26 Benninghoff AD, "Assessment of the estrogen activity of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS) and other structurally diverse perfluorinated chemicals in rainbow trout" 96 : 110-, 2007

27 Loos R, "Analysis of perfluorooctanoate (PFOA) and other perfluorinated compounds (PFCs) in the River Po watershed in N-Italy" 71 : 306-313, 2008

28 Takacs ML, "Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate" 95 : 108-117, 2007

29 Yamashita N, "A global survey of perfluorinated acids in oceans" 51 : 658-668, 2005

30 Perkins RG, "13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats" 27 : 361-378, 2004